Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal

Journal of Clinical Oncology

Volumn 32, Issue 17, 2014, Pages 1812-1817

  Serup Hansen, Eva ^a   Linnemann, Dorte ^a   Skovrider Ruminski, Wojciech ^a   Hgødall, Estrid ^a   Geertsen, Poul Flemming ^a   Havsteen, Hanne ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN; PROTEIN P16;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANUS CARCINOMA; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHEMORADIOTHERAPY; DISEASE SPECIFIC SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS GENOTYPING; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RADIATION DOSE; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; TUMOR BIOPSY; VERY ELDERLY; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; FEMALE; GENES, P16; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84905842870     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.52.3464     Document Type: Article

References (29)

1. Daling JR, Madeleine MM, Johnson LG, et al: Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101:270-280, 2004 (Pubitemid 38890829)
2. Frisch M, Glimelius B, van den Brule AJ, et al: Sexually transmitted infection as a cause of anal cancer. N Engl J Med 337:1350-1358, 1997 (Pubitemid 27467769)
3. Frisch M, Biggar RJ, Goedert JJ: Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92:1500-1510, 2000
4. Penn I: Cancers of the anogenital region in renal transplant recipients: Analysis of 65 cases. Cancer 58:611-616, 1986
5. Tseng HF, Morgenstern H, Mack TM, et al: Risk factors for anal cancer: Results of a population-based case-control study. Cancer Causes Control 14:837-846, 2003 (Pubitemid 37500735)
6. Frisch M: On the etiology of anal squamous carcinoma. Dan Med Bull 49:194-209, 2002
7. Melbye M, Sprøgel P: Aetiological parallel between anal cancer and cervical cancer. Lancet 338:657-659, 1991
8. [No authors listed]: Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin - UKCCCR Anal Cancer Trial Working Party, UK Co-ordinating Committee on Cancer Research. Lancet 348:1049-1054, 1996
9. Bartelink H, Roelofsen F, Eschwege F, et al: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040-2049, 1997 (Pubitemid 27209535)
10. Ajani JA, Winter KA, Gunderson LL, et al: Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: The intergroup trial (RTOG 98-11). Cancer 116:4007-4013, 2010
11. Glynne-Jones R, Sebag-Montefiore D, Adams R, et al: Prognostic factors for recurrence and survival in anal cancer: Generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I). Cancer 119:748-755, 2013
12. Das P, Crane CH, Eng C, et al: Prognostic factors for squamous cell cancer of the anal canal. Gastrointest Cancer Res 2:10-14, 2008
13. Peiffert D, Bey P, Pernot M, et al: Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys 37:313-324, 1997 (Pubitemid 27138714)
14. Abramowitz L, Jacquard AC, Jaroud F, et al: Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study. Int J Cancer 129:433-439, 2011
15. Valmary-Degano S, Jacquin E, Prétet JL, et al: Signature patterns of human papillomavirus type 16 in invasive anal carcinoma. Hum Pathol 44:992-1002, 2013
16. Lewis JS Jr, Thorstad WL, Chernock RD, et al: p16 positive oropharyngeal squamous cell carcinoma: An entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol 34:1088-1096, 2010
17. Reimers N, Kasper HU, Weissenborn SJ, et al: Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 120:1731-1738, 2007 (Pubitemid 46399359)
18. Singhi AD, Westra WH: Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 116:2166-2173, 2010
19. Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24-35, 2010
20. Lassen P, Eriksen JG, Hamilton-Dutoit S, et al: Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 27:1992-1998, 2009
21. Schwarz JK, Lewis JS Jr, Pfeifer J, et al: Prognostic significance of p16 expression in advanced cervical cancer treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 84:153-157, 2012
22. Ajani JA, Wang X, Izzo JG, et al: Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation. Dig Dis Sci 55:1098-1105, 2010
23. Bruland O, Fluge O, Immervoll H, et al: Gene expression reveals two distinct groups of anal carcinomas with clinical implications. Br J Cancer 98:1264-1273, 2008 (Pubitemid 351481671)
24. Williams GR, Lu QL, Love SB, et al: Properties of HPV-positive and HPV-negative anal carcinomas. J Pathol 180:378-382, 1996
25. Yhim HY, Lee NR, Song EK, et al: The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy. Int J Cancer 129:1752-1760, 2011
26. Lindh M, Görander S, Andersson E, et al: Real-time Taqman PCR targeting 14 human papilloma virus types. J Clin Virol 40:321-324, 2007 (Pubitemid 350152007)
27. Schmitz M, Scheungraber C, Herrmann J, et al: Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types. J Clin Virol 44:302-307, 2009
28. El-Naggar AK, Westra WH: p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: A guide for interpretative relevance and consistency. Head Neck 34:459-461, 2012
29. Westra WH: The morphologic profile of HPV-related head and neck squamous carcinoma: Implications for diagnosis, prognosis, and clinical management. Head Neck Pathol 6:S48-S54, 2012